<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03547648</url>
  </required_header>
  <id_info>
    <org_study_id>172208</org_study_id>
    <nct_id>NCT03547648</nct_id>
  </id_info>
  <brief_title>Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding in Thryroidectomies</brief_title>
  <official_title>Comparison of the Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding Points in Thyroidectomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing thyroidectomy will be divided into three groups (30 cm H2O Group I, 40 cm
      H2O Group II, 50 cmH2O Group III). At the end of the operation patients will be applied peak
      airway pressure manually according to involved groups.The time until the first hemorrhage is
      seen in each group or if not seen pressure will be applied for 30 seconds and then will be
      ended.We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure,
      postoperative haemorrhage that required surgery, and postoperative hematomas during peak
      airway pressure increase during the operation in all patients. The 1st hour blood pressure,
      nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery
      unit.

      The primary end point of the study is intraoperative bleeding detected, and the secondary end
      point is postoperative bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be divided into three groups (https://www.randomizer.org/) by computer assisted
      randomization method (30 cm H2O in Group I, 40 cm H2O in Group II, 50 cmH2O in Group III peak
      pressure will be applied). The time until the first hemorrhage is seen in each group or if
      not seen pressure will be applied for 30 seconds and then will be ended.

      Patients will be taken to the operation table and standard monitorization will be performed
      consisting of ECG, non-invasive blood pressure and peripheral O2 saturation from the back
      region. Anesthesia was induced with 2 mg / kg propofol (propofol 1% Fresenius, Fresenius
      Kabi, Germany), 2 mg / kg fentanyl (Talinat 0,5mg / 10ml, AND, Turkey), 0.6 mg / kg
      rocuronium (Muscuro 50mg / 5ml, Kocak Farma , Turkey) will be provided after the patients
      were intubated orally. General anesthesia treatment will be provided with 2% Sevoflurane in
      40% oxygen-air mixture. All patients will be ventilated in pressure controlled mode;
      respiratory frequency: 12 / min, FiO2: 40% (oxygen-air mixture), I/E:1/2, PEEP: 7 cmH2O
      supplying end tidal CO2 value of 32-36 mmHg.

      Calculating the ideal weight of the patient, isolated-S (Polifarma, Turkey)2ml/kg/h will be
      infused. If the systolic arterial pressure (SAB) or heart rate (HR) increases by 20% compared
      to baseline, IV 50 μg fentanyl will be administered. At the end of the operation, the
      patient's airway peak pressure will be increased before hemostasis is provided by the same
      surgeon (S.T.). Positive pressure on the Maquet Flow I device (Maquet Flow I-AGC, Rastatt,
      USA) will be applied manually(30 cm H2O in Group I, 40 cm H2O in Group II patients and 50 cm
      H2O in group III patients). The airway peak pressure increase will be maintained and recorded
      until the surgeon sees the first bleeding point or if not seen for 30 seconds. For all three
      groups this process will be repeated one more time.

      After peak airway pressure is increased, the number of bleeding centers detected, how long
      time did it take to detect and the size of the bleeding vessel (&lt;2 mm or&gt; 2 mm)will be
      recorded. We will record the blood pressure, spO2, HR, the first ETCO2 after the procedure,
      postoperative haemorrhage that required surgery, and postoperative hematomas during peak
      airway pressure increase during the operation in all patients. The 1st hour blood pressure,
      nausea-vomiting score and pain score (NRS) will be recorded in the postoperative recovery
      unit.

      The primary end point of the study is intraoperative bleeding detected, and w the secondary
      end point is postoperative bleeding.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Actual">November 16, 2018</completion_date>
  <primary_completion_date type="Actual">November 16, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative bleeding point</measure>
    <time_frame>30 seconds</time_frame>
    <description>Determination of intraoperative bleeding point just after applying positive airway pressure manually</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative haemorrhage</measure>
    <time_frame>24 hours</time_frame>
    <description>Postoperative haemorrhage for 24 hours postoperatively</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Thyroid Neoplasms</condition>
  <condition>Thyroid Nodule</condition>
  <arm_group>
    <arm_group_label>Group I ( 30 cm H2O)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be applied 30 cm H2O peak airway pressure manually at the end of the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II( 40 cm H2O)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be applied 40 cm H2O peak airway pressure manually at the end of the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III(50 cm H2O)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be applied 50 cm H2O peak airway pressure manually at the end of the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>peak airway pressure</intervention_name>
    <description>Patients' peak airway pressures will be raised to observe intraoperative bleeding in thyroidectomy surgery. Aim is to prevent postoperative bleeding.</description>
    <arm_group_label>Group I ( 30 cm H2O)</arm_group_label>
    <arm_group_label>Group II( 40 cm H2O)</arm_group_label>
    <arm_group_label>Group III(50 cm H2O)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA classification I-II patients

          -  Patients undergoing total thyroidectomy

          -  Aged between 18-60 years

        Exclusion Criteria:

          -  Active pulmonary disease

          -  Cardiac aritmia

          -  Intracranial mass

          -  Coagulation defects
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murat Akcivan, resident</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aylin Özdilek, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emre Erbabacan, Ass Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fatiş Altındaş, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serkan Teksöz, Ass Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Turkey</name>
      <address>
        <city>Istanbul</city>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Kumar CM, Van Zundert AAJ. Intraoperative Valsalva maneuver: a narrative review. Can J Anaesth. 2018 May;65(5):578-585. doi: 10.1007/s12630-018-1074-6. Epub 2018 Jan 24. Review.</citation>
    <PMID>29368315</PMID>
  </reference>
  <results_reference>
    <citation>Tokaç M, Dumlu EG, Bozkurt B, Öcal H, Aydın C, Yalçın A, Çakır B, Kılıç M. Effect of Intraoperative Valsalva Maneuver Application on Bleeding Point Detection and Postoperative Drainage After Thyroidectomy Surgeries. Int Surg. 2015 Jun;100(6):994-8. doi: 10.9738/INTSURG-D-15-00002.1.</citation>
    <PMID>26414819</PMID>
  </results_reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>May 23, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2018</study_first_posted>
  <last_update_submitted>November 18, 2018</last_update_submitted>
  <last_update_submitted_qc>November 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Dr Cigdem Akyol Beyoğlu</investigator_full_name>
    <investigator_title>Anaesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Blood Loss, Surgical</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

